Clinical Trial Update: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study [Phase 3]

View source ↗

Summary

Phase 3 ENLIGHTED study evaluating endoluminal light-activated treatment for transitional cell cancer of the renal pelvis and ureter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Pelvis Cancer
• Transitional Cell Cancer of the Renal Pelvis
• Transitional Cell Carcinoma of the Renal Pelvis
• Ureteral Cancer

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Transitional Cell Cancer of Renal Pelvis and Ureter | Phase 3 | Status: COMPLETED